GenFusAb

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameGenFusAb
Drug Alias Nameanti-fusion oncoprotein single-strand antibody gene therapy (Haplomic Technologies)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionOncogene proteins inhibitors
TargetsOncogene proteins
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHaplomic Technologies Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHaplomic Technologies Pty Ltd
Active IndicationsN/A
Inactive IndicationsLeukemia

Other Information

ATC CodeN/A
Related LinksN/A